Baillie Gifford & Co
JAZZ icon

Baillie Gifford & Co’s Jazz Pharmaceuticals JAZZ Stock Holding History

Baillie Gifford & Co’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-193
Closed -$28.2K – 368
2023
Q1 		$28.2K Buy
193
+25
+15% +$3.7K ﹤0.01% 316
2022
Q4 		$26.8K Hold
168
– – ﹤0.01% 322
2022
Q3 		$22K Hold
168
– – ﹤0.01% 321
2022
Q2 		$26K Buy
168
+3
+2% +$462 ﹤0.01% 319
2022
Q1 		$26K Hold
165
– – ﹤0.01% 335
2021
Q4 		$21K Buy
+165
New +$21.7K ﹤0.01% 370

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return